AKTX vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

AKTX

51.0
AI Score
VS
AKTX Wins

CBIO

46.8
AI Score

Investment Advisor Scores

AKTX

51score
Recommendation
HOLD

CBIO

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AKTX CBIO Winner
Net Income 153,942 -19.26M CBIO
Operating Income -152.63M -20.36M AKTX
ROE 0.1% -103.6% CBIO
ROA 0.1% -49.9% CBIO
Total Assets 240.29M 38.62M CBIO
Cash 213.19M 7.69M CBIO
Current Ratio 6.56 0.60 CBIO
Free Cash Flow -72.45M -5.64M AKTX

Relative Price Performance (Last 90 Days)

AKTX 1M: -15.6% · 3M: +52.7% CBIO 1M: +0.7% · 3M: -15.2%

Current Technical Phase

AKTX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.2 · Price: $7.85

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $17.15

Fundamentals Snapshot

Metric AKTX CBIO
Market Cap
Forward P/E -6.7 -6.5
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 1.0%
Operating Margin 0.0% -14.3%
EPS 0.00 -0.13
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AKTX is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.